NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









InteRNA Technologies

InteRNA Technologies

Private
UtrechtHealthcare & Life Scienceshttps://interna-technologies.com/

Last Round

Series B

Extension

Feb 9, 2021

Total Funding Raised

$34.67M

Company Overview

InteRNA Technologies is a clinical-stage biotechnology company that develops microRNA-based therapeutics for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

microRNA therapeuticsoncology drug developmentlipid nanoparticlemiRNALNP deliverybiotech drug discoveryclinical-stage biotechcancer therapydrug licensingRNA medicineoncology pipelinetherapeutic mimicbiopharma partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InteRNA Technologies Comparables

Compare InteRNA Technologies with similar companies based on industry and business-model similarity.

InteRNA Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Thalia Therapeutics PLC
83%
MiNA Therapeutics
79%
Regulus Therapeutics Inc.
71%

InteRNA Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionFeb 9, 2021
Series ADec 15, 2015
GrantNov 18, 2010

InteRNA Technologies Investors

Notable investors and investment history

InteRNA Technologies investors
InvestorRounds
AurorA ScienceSeries B Extension
Waterman VenturesSeries B Extension
East Netherlands Development Agency (Oost NL)Series B Extension
Aglaia Oncology FundsSeries B Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 9, 2021

    $22M round led by AurorA Science.

  • Nov 18, 2010

    Secured $1.77M in grant funding.

InteRNA Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InteRNA Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InteRNA Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersUtrecht
Year Founded2006
Last FundingFeb 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.